TAVR

TAVR PRODUCT

TAVR

TAVR PRODUCT

TAVR

The Company is one of the only four domestic players in the China market with TAVR products at the clinical trial or more advanced stage, and ranked third in the China transcatheter valve medical device market in terms of the combined number of commercialized products and product candidates in the clinical trial stage, according to Frost & Sullivan, as of December 31, 2019. The Company is also developing the second- and third-generation TAVR products incorporating innovative features.